Evergreen Capital Management LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 7,710 shares of the company’s stock, valued at approximately $777,000.
Several other institutional investors and hedge funds have also modified their holdings of CLX. ProShare Advisors LLC boosted its holdings in shares of Clorox by 11.7% in the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock valued at $159,922,000 after buying an additional 136,135 shares during the period. Vanguard Personalized Indexing Management LLC lifted its position in Clorox by 64.2% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after acquiring an additional 10,065 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Clorox by 27.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after purchasing an additional 197,330 shares during the period. Brookstone Capital Management increased its holdings in Clorox by 1,395.4% during the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock worth $11,631,000 after purchasing an additional 88,024 shares in the last quarter. Finally, Eliot Finkel Investment Counsel LLC bought a new stake in shares of Clorox in the third quarter valued at about $1,697,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Stock Performance
Shares of CLX stock opened at $98.68 on Friday. The company has a fifty day moving average price of $110.40 and a two-hundred day moving average price of $109.48. The Clorox Company has a one year low of $96.58 and a one year high of $143.96. The stock has a market cap of $11.93 billion, a P/E ratio of 16.12, a P/E/G ratio of 0.48 and a beta of 0.65. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the firm earned $1.55 earnings per share. The firm’s revenue for the quarter was down .8% on a year-over-year basis. As a group, equities analysts predict that The Clorox Company will post 5.87 EPS for the current year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.0%. Clorox’s dividend payout ratio is currently 81.05%.
Analyst Upgrades and Downgrades
CLX has been the subject of a number of research reports. Morgan Stanley decreased their price objective on Clorox from $136.00 to $110.00 and set an “equal weight” rating for the company in a report on Wednesday. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a research note on Friday, February 13th. Evercore lowered their price objective on shares of Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a report on Wednesday, February 4th. Royal Bank Of Canada reduced their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Clorox from $101.00 to $100.00 and set a “hold” rating for the company in a research report on Monday, April 20th. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average target price of $111.33.
Read Our Latest Analysis on Clorox
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
Receive News & Ratings for Clorox Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clorox and related companies with MarketBeat.com’s FREE daily email newsletter.
